Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01903187 · ClinicalTrials.gov registry record · NA
EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01903187: Clinical Trial NA study, sponsored by Abbott Medical Devices.
NCT01903187 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01903187, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the EnligHTN IV clinical investigation is to demonstrate the safety and effectiveness of the EnligHTN™ Renal Denervation System in the treatment of subjects with drug-resistant uncontrolled hypertension.
Primary Outcome
The study enrollment was terminated early by the sponsor. This was not related to any safety issue. At the time enrollment was halted, only 2 treatment group randomizations had occurred.
Interventions
- PROCEDURE Sham
- DEVICE EnligHTN Renal Denervation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-11 |
| Phase | NA |
Why NCT01903187 stopped before completion
NCT01903187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT01903187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01903187 about?
NCT01903187 is a clinical study titled "EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension". The purpose of the EnligHTN IV clinical investigation is to demonstrate the safety and effectiveness of the EnligHTN™ Renal Denervation System in the treatment of subjects with drug-resistant uncontrolled hypertension.
What is the current status of trial NCT01903187?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2013-10. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01903187?
The interventions under investigation include: Sham (PROCEDURE), EnligHTN Renal Denervation (DEVICE).
Who is sponsoring clinical trial NCT01903187?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01903187's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia